Upgrade

Liminatus Pharma, Inc.

LIMN

Last
$3.76
Day
+1.9%
1y
-95.2%
5y
-99.3%
52w
-97.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
3.90
EMA 50
4.52
EMA 200
39.13
20d high
-17.6%
5y high
-99.8%
5y range
0th
Website · 1 employees · United States

Positions held

Your positions

LIMN isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
5
Hold
watch
Signal
Neutral
Target
$4.27
Stop
$3.21
Stop distance
14.6%
Target vs last
+13.6%

Fundamentals

Market cap$4.96MEnterprise value$3.38MTrailing P/E—Forward P/E—
PEG—Price / book13.72Beta0.75Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE—ROA-95.7%Debt / equity4.80
Current ratio1.12Free cash flow-$10.01MAnalyst recommendationnoneMean target—
52w high$141.5052w low$3.29

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M—$0.0M
Op margin——————
Net income-$1.4M-$1.1M-$8.2M-$1.8M—-$0.3M
Gross margin——————
Gross profit——————
Operating income-$1.4M-$1.1M-$0.9M-$0.7M—-$0.3M

Yearly (6y)

2025202420232022
Revenue$0.0M$0.0M$0.0M$0.0M
Op margin————
Net income-$10.2M-$3.5M-$5.0M-$2.9M
Gross margin————
Gross profit————
Operating income-$3.0M-$3.3M-$4.8M-$2.7M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

LIMN · daily-9.3% over 13 sessions
Close EMA21 EMA50 EMA200
3.483.744.014.274.532026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$8M-$6M-$4M-$2M$0M0%5%10%2025-Q12025-Q32025-Q42026-Q12026-Q2